缺血性卒中最初24小时内的血压管理
高血压在缺血性卒中后常见,与功能预后差和死亡率增加相关。多项大型降压试验未能改变结局,无论治疗在院前社区还是医院开始。本叙述性综述探讨了不同病因、药物类型与时机、降压速度及对脑灌注和血小板影响等细节,以及溶栓和取栓前后等特定场景的血压管理问题。
要点
- 高血压在缺血性卒中后常见,与功能预后差和死亡率增加相关。
- 多项大型降压试验未能改变结局,无论治疗在院前社区还是医院开始。
- 不同亚组患者可能需要降压、不予干预或升高血压。
核心结论
- 尽管进一步的大型试验正在进行中,越来越可能的是没有简单的答案。
- 不同亚组患者可能需要降低血压(例如溶栓前或溶栓后)、不予干预或升高血压。
研究设计与样本
- 本叙述性综述探讨了缺血性卒中最初24小时内血压管理的相关问题。
主要发现
- 高血压在缺血性卒中后常见,与功能预后差和死亡率增加相关。
- 多项大型降压试验未能改变结局,无论治疗在院前社区还是医院开始。
- 需要关注不同病因是否需要不同干预、药物类型与时机、降压速度以及药物对脑灌注和血小板等附带效应。
- 特定场景包括静脉溶栓和血管内治疗/取栓术前、术中、术后何时降压、何时可能需要升高血压以及卒中前服用的降压药何时重启。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
High blood pressure (BP) is common after ischemic stroke and associated with a poor functional outcome and increased mortality. The conundrum then arises on whether to lower BP to improve outcome or whether this will worsen cerebral perfusion due to aberrant cerebral autoregulation. A number of large trials of BP lowering have failed to change outcome whether treatment was started prehospital in the community or hospital. Hence, nuances on how to manage high BP are likely, including whether different interventions are needed for different causes, the type and timing of the drug, how quickly BP is lowered, and the collateral effects of the drug, including on cerebral perfusion and platelets. Specific scenarios are also important, including when to lower BP before, during, and after intravenous thrombolysis and endovascular therapy/thrombectomy, when it may be necessary to raise BP, and when antihypertensive drugs taken before stroke should be restarted. This narrative review addresses these and other questions. Although further large trials are ongoing, it is increasingly likely that there is no simple answer. Different subgroups of patients may need to have their BP lowered (eg, before or after thrombolysis), left alone, or elevated.
引用
- Bath PM, Song L, Silva GS, et al. Blood Pressure Management for Ischemic Stroke in the First 24 Hours. Stroke. 2022. PMID: 35291822. doi:10.1161/STROKEAHA.121.036143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。